News

Assembly News

The Efficacy and Safety of Colistimethate Sodium Delivered Via the I-neb in Patients with Bronchiectasis and Pseudomonas aeruginosa Infection: the PROMIS-I and PROMIS-II Randomized Controlled Trials

Date & Time

Feb 13, 2025 11:00 AM  in  Central Time (US and Canada)

Description

Farheen Surthie, MD from Tulane University will present the article titled ‘The Efficacy and Safety of Colistimethate Sodium Delivered Via the I-neb in Patients with Bronchiectasis and Pseudomonas aeruginosa Infection: the PROMIS-I and PROMIS-II Randomized Controlled Trials; The Lancet Respiratory Medicine, Volume 12, Issue 10, 787 – 798’. The session will be moderated by Divya Reddy, MBBS, MPH from Albert Einstein College of Medicine/Montefiore Medical Center and we will be joined by expert panelists; James Chalmers, MD from University of Dundee and Tim Aksamit, MD from Mayo Clinic.

Register Here

Assembly Newsletters

NTM-TB Insights Newsletter